Astrocytes in Neuropathologies Affecting the Frontal Cortex
- PMID: 30809131
- PMCID: PMC6379461
- DOI: 10.3389/fncel.2019.00044
Astrocytes in Neuropathologies Affecting the Frontal Cortex
Abstract
To an increasing extent, astrocytes are connected with various neuropathologies. Astrocytes comprise of a heterogeneous population of cells with region- and species-specific properties. The frontal cortex exhibits high levels of plasticity that is required for high cognitive functions and memory making this region especially susceptible to damage. Aberrations in the frontal cortex are involved with several cognitive disorders, including Alzheimer's disease, Huntington's disease and frontotemporal dementia. Human induced pluripotent stem cells (iPSCs) provide an alternative for disease modeling and offer possibilities for studies to investigate pathological mechanisms in a cell type-specific manner. Patient-specific iPSC-derived astrocytes have been shown to recapitulate several disease phenotypes. Addressing astrocyte heterogeneity may provide an improved understanding of the mechanisms underlying neurodegenerative diseases.
Keywords: Alzheimer’s disease; Huntington’s disease; astrocyte; frontal cortex; frontotemporal dementia; induced pluripotent stem cells; neurodegeneration.
Similar articles
-
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019. PLoS One. 2019. PMID: 30897183 Free PMC article.
-
Modeling astrocytic contribution toward neurodegeneration with pluripotent stem cells: focus on Alzheimer's and Parkinson's diseases.Neuroreport. 2013 Dec 18;24(18):1053-7. doi: 10.1097/WNR.0000000000000064. Neuroreport. 2013. PMID: 24201446 Review.
-
Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges.N Biotechnol. 2017 Oct 25;39(Pt B):190-198. doi: 10.1016/j.nbt.2017.05.009. Epub 2017 Jun 2. N Biotechnol. 2017. PMID: 28579476 Review.
-
Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.Open Biol. 2019 Jan 31;9(1):180177. doi: 10.1098/rsob.180177. Open Biol. 2019. PMID: 30958120 Free PMC article. Review.
-
Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.Mol Neurodegener. 2015 Sep 15;10:46. doi: 10.1186/s13024-015-0042-7. Mol Neurodegener. 2015. PMID: 26373282 Free PMC article.
Cited by
-
Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies.Stem Cell Rev Rep. 2019 Dec;15(6):795-813. doi: 10.1007/s12015-019-09910-6. Stem Cell Rev Rep. 2019. PMID: 31863335 Review.
-
Chronic Stress Alters Astrocyte Morphology in Mouse Prefrontal Cortex.Int J Neuropsychopharmacol. 2021 Oct 23;24(10):842-853. doi: 10.1093/ijnp/pyab052. Int J Neuropsychopharmacol. 2021. PMID: 34346493 Free PMC article.
-
Gentiacaulein inhibits glucose transport to induce PRKAA1-mediated autophagy to clear amyloid beta and associated inflammation in primary astrocytes.Autophagy Rep. 2024 Jan 5;3(1):2296209. doi: 10.1080/27694127.2023.2296209. eCollection 2024. Autophagy Rep. 2024. PMID: 40395536 Free PMC article.
-
The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes.J Neuroinflammation. 2022 Apr 12;19(1):93. doi: 10.1186/s12974-022-02442-w. J Neuroinflammation. 2022. PMID: 35413853 Free PMC article.
-
Astrocytes: Role and Functions in Brain Pathologies.Front Pharmacol. 2019 Sep 27;10:1114. doi: 10.3389/fphar.2019.01114. eCollection 2019. Front Pharmacol. 2019. PMID: 31611796 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources